The MNB/DYRK1A protein kinase: genetic and biochemical properties
- PMID: 15068246
- DOI: 10.1007/978-3-7091-6721-2_12
The MNB/DYRK1A protein kinase: genetic and biochemical properties
Abstract
The "Down syndrome critical region" of human chromosome 21 has been defined based on the analysis of rare cases of partial trisomy 21. Evidence is accumulating that DYRK1A, one of the 20 genes located in this region, is an important candidate gene involved in the neurobiological alterations of Down syndrome. Both the structure of the DYRK1A gene and the sequence of the encoded protein kinase are highly conserved in evolution. The protein contains a unique assembly of structural motifs outside the catalytic domain, including a nuclear localization signal, a PEST region, and a repeat of 13 consecutive histidines. MNB/DYRK1A and related kinases are unique among serine/threonine-specific protein kinases in that their activity depends on tyrosine autophosphorylation in the catalytic domain. Also, evidence is accumulating that mRNA levels of MNB/DYRK1A are subject to tight regulation. A number of putative substrates of MNB/DYRK1A have emerged in the recent years, the majority of them being transcription factors. Although the function of MNB/DYRK1A in intracellular signalling and regulation of cell function is still poorly defined, current evidence suggests that the kinase may play a role in the regulation of gene expression.
Similar articles
-
The MNB/DYRK1A protein kinase: neurobiological functions and Down syndrome implications.J Neural Transm Suppl. 2003;(67):129-37. doi: 10.1007/978-3-7091-6721-2_11. J Neural Transm Suppl. 2003. PMID: 15068245 Review.
-
The spatio-temporal and subcellular expression of the candidate Down syndrome gene Mnb/Dyrk1A in the developing mouse brain suggests distinct sequential roles in neuronal development.Eur J Neurosci. 2008 Mar;27(5):1061-74. doi: 10.1111/j.1460-9568.2008.06092.x. Eur J Neurosci. 2008. PMID: 18364031
-
DYRK1A: a potential drug target for multiple Down syndrome neuropathologies.CNS Neurol Disord Drug Targets. 2014 Feb;13(1):26-33. doi: 10.2174/18715273113126660186. CNS Neurol Disord Drug Targets. 2014. PMID: 24152332 Review.
-
High-level expression of the Mnb/Dyrk1A gene in brain and heart during rat early development.Genomics. 1999 Dec 1;62(2):165-71. doi: 10.1006/geno.1999.5998. Genomics. 1999. PMID: 10610708
-
Cloning of a human homolog of the Drosophila minibrain/rat Dyrk gene from "the Down syndrome critical region" of chromosome 21.Biochem Biophys Res Commun. 1996 Aug 5;225(1):92-9. doi: 10.1006/bbrc.1996.1135. Biochem Biophys Res Commun. 1996. PMID: 8769099
Cited by
-
Dyrk1A potentiates steroid hormone-induced transcription via the chromatin remodeling factor Arip4.Mol Cell Biol. 2004 Jul;24(13):5821-34. doi: 10.1128/MCB.24.13.5821-5834.2004. Mol Cell Biol. 2004. PMID: 15199138 Free PMC article.
-
Identification of FAM53C as a cytosolic-anchoring inhibitory binding protein of the kinase DYRK1A.Life Sci Alliance. 2023 Oct 6;6(12):e202302129. doi: 10.26508/lsa.202302129. Print 2023 Dec. Life Sci Alliance. 2023. PMID: 37802655 Free PMC article.
-
GR/Ahi1 regulates WDR68-DYRK1A binding and mediates cognitive impairment in prenatally stressed offspring.Cell Mol Life Sci. 2024 Jan 10;81(1):20. doi: 10.1007/s00018-023-05075-1. Cell Mol Life Sci. 2024. PMID: 38195774 Free PMC article.
-
A De Novo Mutation in DYRK1A Causes Syndromic Intellectual Disability: A Chinese Case Report.Front Genet. 2019 Nov 19;10:1194. doi: 10.3389/fgene.2019.01194. eCollection 2019. Front Genet. 2019. PMID: 31803247 Free PMC article.
-
Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): molecular basis, functions and role in diseases.Cell Mol Life Sci. 2020 Dec;77(23):4747-4763. doi: 10.1007/s00018-020-03556-1. Epub 2020 May 27. Cell Mol Life Sci. 2020. PMID: 32462403 Free PMC article. Review.